Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Georgian Med News ; (131): 49-52, 2006 Feb.
Article in Russian | MEDLINE | ID: mdl-16575132

ABSTRACT

The aim of the work was to study the effect of metabolic triad with different mechanisms of acting--high-dose Glucose-Insulin-Potassium--25% polarizing solution (25% glucose, 50 IU soluble insulin and 4% 144 ml KCL-GIK), mildronat, preductal MR on the functional condition of heart during the acute myocardial infarction. 20 patients from the main group and 20 from the control one have been under the study. Patients with diabetes and heavy forms of heart failure (killip class>2) were not included in the study. Evaluation of the functional condition of heart was based on ECG and echocardiography data received before and after the treatment. It was determined that the frequency of the rhythm disorder decreases in the conditions of metabolic triad as well as during the thrombolitic reperfusion. Average period of time for normalization of S-T segment elevation made up 5.4+/-1.8 days and 7.3+/-1.2 days in case of the control group. The received data make it relevant to include the complex metabolic triad for preventive purpose during the complications followed after the acute myocardial infarction.


Subject(s)
Cardiovascular Agents/therapeutic use , Methylhydrazines/therapeutic use , Myocardial Infarction/drug therapy , Trimetazidine/therapeutic use , Vasodilator Agents/therapeutic use , Adult , Aged , Drug Therapy, Combination , Female , Glucose/therapeutic use , Humans , Insulin/therapeutic use , Male , Middle Aged , Potassium/therapeutic use
2.
Georgian Med News ; (123): 18-21, 2005 Jun.
Article in Russian | MEDLINE | ID: mdl-16052048

ABSTRACT

The safety and efficiency of the therapy with the angiotenzin-II receptor blocker--teveten were compared with the ACE inhibitor prestarium and their combination in patients with NYHA functional classes II-III of the chronic heart failure (CHF), who were on conventional therapy with diuretics and cardiac glycosides. The special attention was given to the influence of a combination of teveten and prestarium on morphofunctional performance of the myocardium and vessels, the neurohumoral status, quality of life and survival in patients with left ventricular dysfunction. Our study confirmed that Prestarium or Teveten monotheraphy gives approximately identical result, while their combination have better influence on the quality of life and hemodynamic parameters. The combined use of teveten and the ACE inhibitor prestarium is the most optimal treatment regimen in patients with moderate and severe CHF.


Subject(s)
Acrylates/therapeutic use , Antihypertensive Agents/therapeutic use , Heart Failure/drug therapy , Heart Failure/physiopathology , Imidazoles/therapeutic use , Perindopril/therapeutic use , Thiophenes/therapeutic use , Chronic Disease , Drug Therapy, Combination , Female , Humans , Male
3.
Kardiologiia ; 21(6): 48-51, 1981 Jun.
Article in Russian | MEDLINE | ID: mdl-7265632

ABSTRACT

Blood serum antioxidation activity (AOA) was studied by the biophysical method of inhibited electrochemiluminescence in 500 patients with acute myocardial infarction. The degree of increased AOA depends on the size of the affected area. AOA intensity is greater in macrofocal than in microfocal myocardial infarction. It was established that in non-complicated myocardial infarction AOA is characterized by smooth dynamics with normalization of the values on the 3d week. Rapid AOA dynamics are encountered in II or III degree chronic congestive circulatory insufficiency. Protracted dynamics of antioxidation activity (longer than 3 weeks) is evidence of a recurrent character of the disease.


Subject(s)
Blood/metabolism , Electrocardiography , Myocardial Infarction/blood , Adult , Aged , Arrhythmias, Cardiac/physiopathology , Free Radicals , Heart Failure/physiopathology , Humans , Luminescent Measurements , Middle Aged , Myocardial Infarction/complications , Myocardial Infarction/physiopathology , Oxidation-Reduction , Shock, Cardiogenic/physiopathology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL